Pancreatic beta-cell secretory defect associated with mitochondrial point mutation of the tRNALEU(UUR) gene: a study in seven families with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS)

S. Suzuki, Y. Hinokio, S. Hirai, M. Onoda, M. Matsumoto, M. Ohtomo, H. Kawasaki, Y. Satoh, H. Akai, Koji Abe, S. Miyabayashi, E. Kawasaki, S. Nagataki, T. Toyota

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

Recent evidence suggests possible linkage between diabetes mellitus and mitochondrial gene mutation. We surveyed mitochondrial tRNALEU(UUR) (3243) mutation in 7 mitochondrial encephalomyopathy, lactic acidosis and stroke-like episode (MELAS) families and identified 24 mutated subjects (7 MELAS probands and 17 non-MELAS relatives) as well as 11 non-mutant family members. An OGTT in the 24 mutant relatives revealed 14 diabetic subjects, 3 with impaired glucose tolerance and 7 with normal glucose tolerance and all non-mutant family members as having normal glucose tolerance. Insulinogenic index was significantly reduced in the mutant diabetic subjects and those with impaired and normal glucose tolerance in comparison with the normal control subjects and the non-mutant members. Urinary 24-h C-peptide immunoreactivity excretion was markedly reduced in the mutant diabetic subjects and those with normal and impaired glucose tolerance, compared with the control subjects and the non-mutant family members. Plasma C-peptide immunoreactivity 6 min after glucagon injection was markedly reduced in the mutant diabetic subjects and those with normal and impaired glucose tolerance compared with the control subjects and the non-mutant family members. Si, an index of insulin sensitivity of the four mutant subjects was within normal range. Islet cell antibodies were negative in sera of eight mutated diabetic subjects, 2 and 6 with impaired and normal glucose tolerance, respectively. Diabetic retinopathy and nephropathy were demonstrated in 7 (50%) and 12 (85.7%) of 14 mutant diabetic subjects, respectively. Neurosensory deafness was demonstrated in 12 (85.7%) of 14 mutated diabetic subjects, (66.7%) of 3 mutated impaired glucose tolerant subjects, but not detected in 6 mutated normal glucose tolerant subjects and 11 non-mutant family members. These findings suggest that the tRNALEU(UUR) mutation is associated with pancreatic beta-cell secretory defect of insulin.

Original languageEnglish
Pages (from-to)818-825
Number of pages8
JournalDiabetologia
Volume37
Issue number8
DOIs
Publication statusPublished - Aug 1994
Externally publishedYes

Fingerprint

MELAS Syndrome
Insulin-Secreting Cells
Glucose Intolerance
Point Mutation
Genes
Glucose
C-Peptide
Mutation
Lactic Acidosis
Mitochondrial Genes
Diabetic Nephropathies
Deafness
Diabetic Retinopathy
Glucose Tolerance Test
Glucagon
Insulin Resistance
Diabetes Mellitus
Reference Values
Stroke
Insulin

Keywords

  • C-peptide
  • diabetes mellitus
  • insulin secretion
  • MELAS
  • mitochondrial gene mutation

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Pancreatic beta-cell secretory defect associated with mitochondrial point mutation of the tRNALEU(UUR) gene : a study in seven families with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS). / Suzuki, S.; Hinokio, Y.; Hirai, S.; Onoda, M.; Matsumoto, M.; Ohtomo, M.; Kawasaki, H.; Satoh, Y.; Akai, H.; Abe, Koji; Miyabayashi, S.; Kawasaki, E.; Nagataki, S.; Toyota, T.

In: Diabetologia, Vol. 37, No. 8, 08.1994, p. 818-825.

Research output: Contribution to journalArticle

Suzuki, S, Hinokio, Y, Hirai, S, Onoda, M, Matsumoto, M, Ohtomo, M, Kawasaki, H, Satoh, Y, Akai, H, Abe, K, Miyabayashi, S, Kawasaki, E, Nagataki, S & Toyota, T 1994, 'Pancreatic beta-cell secretory defect associated with mitochondrial point mutation of the tRNALEU(UUR) gene: a study in seven families with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS)', Diabetologia, vol. 37, no. 8, pp. 818-825. https://doi.org/10.1007/BF00404339
Suzuki, S. ; Hinokio, Y. ; Hirai, S. ; Onoda, M. ; Matsumoto, M. ; Ohtomo, M. ; Kawasaki, H. ; Satoh, Y. ; Akai, H. ; Abe, Koji ; Miyabayashi, S. ; Kawasaki, E. ; Nagataki, S. ; Toyota, T. / Pancreatic beta-cell secretory defect associated with mitochondrial point mutation of the tRNALEU(UUR) gene : a study in seven families with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS). In: Diabetologia. 1994 ; Vol. 37, No. 8. pp. 818-825.
@article{e9ad1bdd4757453ba14d435fbd25e8de,
title = "Pancreatic beta-cell secretory defect associated with mitochondrial point mutation of the tRNALEU(UUR) gene: a study in seven families with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS)",
abstract = "Recent evidence suggests possible linkage between diabetes mellitus and mitochondrial gene mutation. We surveyed mitochondrial tRNALEU(UUR) (3243) mutation in 7 mitochondrial encephalomyopathy, lactic acidosis and stroke-like episode (MELAS) families and identified 24 mutated subjects (7 MELAS probands and 17 non-MELAS relatives) as well as 11 non-mutant family members. An OGTT in the 24 mutant relatives revealed 14 diabetic subjects, 3 with impaired glucose tolerance and 7 with normal glucose tolerance and all non-mutant family members as having normal glucose tolerance. Insulinogenic index was significantly reduced in the mutant diabetic subjects and those with impaired and normal glucose tolerance in comparison with the normal control subjects and the non-mutant members. Urinary 24-h C-peptide immunoreactivity excretion was markedly reduced in the mutant diabetic subjects and those with normal and impaired glucose tolerance, compared with the control subjects and the non-mutant family members. Plasma C-peptide immunoreactivity 6 min after glucagon injection was markedly reduced in the mutant diabetic subjects and those with normal and impaired glucose tolerance compared with the control subjects and the non-mutant family members. Si, an index of insulin sensitivity of the four mutant subjects was within normal range. Islet cell antibodies were negative in sera of eight mutated diabetic subjects, 2 and 6 with impaired and normal glucose tolerance, respectively. Diabetic retinopathy and nephropathy were demonstrated in 7 (50{\%}) and 12 (85.7{\%}) of 14 mutant diabetic subjects, respectively. Neurosensory deafness was demonstrated in 12 (85.7{\%}) of 14 mutated diabetic subjects, (66.7{\%}) of 3 mutated impaired glucose tolerant subjects, but not detected in 6 mutated normal glucose tolerant subjects and 11 non-mutant family members. These findings suggest that the tRNALEU(UUR) mutation is associated with pancreatic beta-cell secretory defect of insulin.",
keywords = "C-peptide, diabetes mellitus, insulin secretion, MELAS, mitochondrial gene mutation",
author = "S. Suzuki and Y. Hinokio and S. Hirai and M. Onoda and M. Matsumoto and M. Ohtomo and H. Kawasaki and Y. Satoh and H. Akai and Koji Abe and S. Miyabayashi and E. Kawasaki and S. Nagataki and T. Toyota",
year = "1994",
month = "8",
doi = "10.1007/BF00404339",
language = "English",
volume = "37",
pages = "818--825",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer Verlag",
number = "8",

}

TY - JOUR

T1 - Pancreatic beta-cell secretory defect associated with mitochondrial point mutation of the tRNALEU(UUR) gene

T2 - a study in seven families with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS)

AU - Suzuki, S.

AU - Hinokio, Y.

AU - Hirai, S.

AU - Onoda, M.

AU - Matsumoto, M.

AU - Ohtomo, M.

AU - Kawasaki, H.

AU - Satoh, Y.

AU - Akai, H.

AU - Abe, Koji

AU - Miyabayashi, S.

AU - Kawasaki, E.

AU - Nagataki, S.

AU - Toyota, T.

PY - 1994/8

Y1 - 1994/8

N2 - Recent evidence suggests possible linkage between diabetes mellitus and mitochondrial gene mutation. We surveyed mitochondrial tRNALEU(UUR) (3243) mutation in 7 mitochondrial encephalomyopathy, lactic acidosis and stroke-like episode (MELAS) families and identified 24 mutated subjects (7 MELAS probands and 17 non-MELAS relatives) as well as 11 non-mutant family members. An OGTT in the 24 mutant relatives revealed 14 diabetic subjects, 3 with impaired glucose tolerance and 7 with normal glucose tolerance and all non-mutant family members as having normal glucose tolerance. Insulinogenic index was significantly reduced in the mutant diabetic subjects and those with impaired and normal glucose tolerance in comparison with the normal control subjects and the non-mutant members. Urinary 24-h C-peptide immunoreactivity excretion was markedly reduced in the mutant diabetic subjects and those with normal and impaired glucose tolerance, compared with the control subjects and the non-mutant family members. Plasma C-peptide immunoreactivity 6 min after glucagon injection was markedly reduced in the mutant diabetic subjects and those with normal and impaired glucose tolerance compared with the control subjects and the non-mutant family members. Si, an index of insulin sensitivity of the four mutant subjects was within normal range. Islet cell antibodies were negative in sera of eight mutated diabetic subjects, 2 and 6 with impaired and normal glucose tolerance, respectively. Diabetic retinopathy and nephropathy were demonstrated in 7 (50%) and 12 (85.7%) of 14 mutant diabetic subjects, respectively. Neurosensory deafness was demonstrated in 12 (85.7%) of 14 mutated diabetic subjects, (66.7%) of 3 mutated impaired glucose tolerant subjects, but not detected in 6 mutated normal glucose tolerant subjects and 11 non-mutant family members. These findings suggest that the tRNALEU(UUR) mutation is associated with pancreatic beta-cell secretory defect of insulin.

AB - Recent evidence suggests possible linkage between diabetes mellitus and mitochondrial gene mutation. We surveyed mitochondrial tRNALEU(UUR) (3243) mutation in 7 mitochondrial encephalomyopathy, lactic acidosis and stroke-like episode (MELAS) families and identified 24 mutated subjects (7 MELAS probands and 17 non-MELAS relatives) as well as 11 non-mutant family members. An OGTT in the 24 mutant relatives revealed 14 diabetic subjects, 3 with impaired glucose tolerance and 7 with normal glucose tolerance and all non-mutant family members as having normal glucose tolerance. Insulinogenic index was significantly reduced in the mutant diabetic subjects and those with impaired and normal glucose tolerance in comparison with the normal control subjects and the non-mutant members. Urinary 24-h C-peptide immunoreactivity excretion was markedly reduced in the mutant diabetic subjects and those with normal and impaired glucose tolerance, compared with the control subjects and the non-mutant family members. Plasma C-peptide immunoreactivity 6 min after glucagon injection was markedly reduced in the mutant diabetic subjects and those with normal and impaired glucose tolerance compared with the control subjects and the non-mutant family members. Si, an index of insulin sensitivity of the four mutant subjects was within normal range. Islet cell antibodies were negative in sera of eight mutated diabetic subjects, 2 and 6 with impaired and normal glucose tolerance, respectively. Diabetic retinopathy and nephropathy were demonstrated in 7 (50%) and 12 (85.7%) of 14 mutant diabetic subjects, respectively. Neurosensory deafness was demonstrated in 12 (85.7%) of 14 mutated diabetic subjects, (66.7%) of 3 mutated impaired glucose tolerant subjects, but not detected in 6 mutated normal glucose tolerant subjects and 11 non-mutant family members. These findings suggest that the tRNALEU(UUR) mutation is associated with pancreatic beta-cell secretory defect of insulin.

KW - C-peptide

KW - diabetes mellitus

KW - insulin secretion

KW - MELAS

KW - mitochondrial gene mutation

UR - http://www.scopus.com/inward/record.url?scp=0027939581&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027939581&partnerID=8YFLogxK

U2 - 10.1007/BF00404339

DO - 10.1007/BF00404339

M3 - Article

C2 - 7988784

AN - SCOPUS:0027939581

VL - 37

SP - 818

EP - 825

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 8

ER -